Monday, December 18, 2017

BRIEF-US FDA Accepts Tagrisso Submission For 1St-Line Nsclc

* ‍US FDA ACCEPTS REGULATORY SUBMISSION FOR TAGRISSO IN 1ST-LINE EGFR-MUTATED NON-SMALL CELL LUNG CANCER​ Source text for Eikon: Further company coverage:

by support@endlesssupplies.biz via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)